Catalyst Wire Dossier Catalyst Wire Dossier

reslizumab

reslizumab · Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for reslizumab, covering 2014-03-31 to 2024-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma [Phase 4]

See pricing